Home/Filings/4/0000950170-23-068899
4//SEC Filing

Lee David K 4

Accession 0000950170-23-068899

CIK 0001808865other

Filed

Dec 6, 7:00 PM ET

Accepted

Dec 7, 8:17 PM ET

Size

5.3 KB

Accession

0000950170-23-068899

Insider Transaction Report

Form 4
Period: 2023-12-05
Lee David K
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-12-05+44,76644,766 total
    Exercise: $9.84Exp: 2033-12-05Common Stock (44,766 underlying)
Footnotes (1)
  • [F1]This stock option shall vest over 3 years, with 1/3 vesting on December 5, 2024, and thereafter in equal monthly installments over the next 24 months, subject to the Reporting Person's continued service as a director through the applicable vesting date.

Documents

1 file

Issuer

iTeos Therapeutics, Inc.

CIK 0001808865

Entity typeother

Related Parties

1
  • filerCIK 0002002238

Filing Metadata

Form type
4
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 8:17 PM ET
Size
5.3 KB